Pittsburgh, PA · Founded 2020 · Privately Held (backing)
Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments. Duo Oncology is based in Pittsburgh, PA and was founded in 2020. It was valued at $25 million at its seed round in Jun 2025, the last priced event on record. It has raised $13.1 million across 3 recorded rounds; the latest was a $1.4 million seed round in Jun 2025.
PMV mark · valuation
$25.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$13.1M
Last round
Seed Round
Jun 2025
Team — not yet on record
No current team members for Duo Oncology are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Duo Oncology with a free account
·Watch Duo Oncology: the Monday email on marks, rounds and moves
